Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1621 1625
This examiner grants 69% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18472992 | CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-RECEIVING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS AND ELECTRONIC DEVICE INCLUDING THE LIGHT-RECEIVING DEVICE | Non-Final OA | Samsung Display Co., Ltd. |
| 18567873 | SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANT | Final Rejection | DANA-FARBER CANCER INSTITUTE, INC. |
| 17428080 | IMMUNOPHILIN-DEPENDENT INHIBITORS AND USES THEREOF | Final Rejection | The Regents of the University of California |
| 18263340 | METHODS OF TREATING CANCER WITH POZIOTINIB | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17642285 | BIFUNCTIONAL DEGRADERS AND THEIR METHODS OF USE | Non-Final OA | NOVARTIS AG |
| 18042466 | SUBSTITUTED N-PHENYLURACILS AND SALTS THEREOF, AND USE THEREOF AS HERBICIDAL ACTIVE SUBSTANCES | Non-Final OA | Bayer Aktiengesellschaft |
| 18027785 | TRIAZINE COMPOUND, MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, ELECTRON TRANSPORT MATERIAL FOR ORGANIC LIGHT EMITTING DIODE, AND ORGANIC LIGHT EMITTING DIODE | Final Rejection | TOSOH CORPORATION |
| 18573790 | CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH | Non-Final OA | CELGENE CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy